Literature DB >> 10805209

Liver-infiltrating T lymphocytes are attracted selectively by IFN-inducible protein-10.

M Tamaru1, K Nishioji, Y Kobayashi, Y Watanabe, Y Itoh, T Okanoue, M Murai, K Matsushima, S Narumi.   

Abstract

We have demonstrated that interferon-inducible protein-10 (IP-10) is produced in hepatocytes surrounded by infiltrative mononuclear cells in chronic hepatitis. To clarify the role of IP-10 in hepatitis, we examined the chemoattractive activity of IP-10 on liver-infiltrating lymphocytes in experimental animal models of hepatitis. IP-10 was specifically induced in the livers of mice treated intravenously (i.v.) with Con A, while monocyte chemotactic protein-1 (MCP-1) showed a much lower level of induction and neither RANTES nor macrophage inflammatory protein-1alpha (MIP-1alpha) was detected. The liver-infiltrating lymphocytes in Con A-induced hepatitis were attracted only by IP-10, and not by other chemokines such as RANTES, MCP-1 and MIP-1alpha. The chemoattractive effect of IP-10 was dose-dependent and was neutralized by monoclonal antibodies to IP-10. The specific effect of IP-10 on liver-infiltrating lymphocytes was also seen on those obtained from rat livers with fulminant hepatitis induced by sequential treatment with killed Propionibacterium acnes (P. acnes) and LPS. Peripheral blood lymphocytes were slightly attracted by IP-10 as well as RANTES and MIP-1alpha, while hepatic resident lymphocytes were not. On the other hand, thioglycolate-elicited peritoneal macrophages did not respond to IP-10, although they did show a response to RANTES, MCP-1 and MIP-1alpha. These results indicated that IP-10 is a specific chemoattractant for T lymphocytes in the inflammatory liver tissues and may play a specific role in the development of hepatitis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10805209     DOI: 10.1006/cyto.1999.0560

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  11 in total

1.  Optimal CD4 T cell priming after LPS-based adjuvanticity with CD134 costimulation relies on CXCL9 production.

Authors:  Paurvi Shinde; Wenhai Liu; Antoine Ménoret; Andrew D Luster; Anthony T Vella
Journal:  J Leukoc Biol       Date:  2017-04-21       Impact factor: 4.962

2.  (-)-Epigallocatechin-3-gallate protects mice from concanavalin A-induced hepatitis through suppressing immune-mediated liver injury.

Authors:  Y Wang; Y Mei; D Feng; L Xu
Journal:  Clin Exp Immunol       Date:  2006-09       Impact factor: 4.330

3.  CXCL10 promotes liver fibrosis by prevention of NK cell mediated hepatic stellate cell inactivation.

Authors:  Edith Hintermann; Monika Bayer; Josef M Pfeilschifter; Andrew D Luster; Urs Christen
Journal:  J Autoimmun       Date:  2010-10-06       Impact factor: 7.094

4.  CXC chemokine ligand 10 DNA vaccination plus Complete Freund's Adjuvant reverses hyperglycemia in non-obese diabetic mice.

Authors:  Yoichi Oikawa; Akira Shimada; Yoshifumi Yamada; Yoshiaki Okubo; Takeshi Katsuki; Toshikatsu Shigihara; Jun-Ichi Miyazaki; Shosaku Narumi; Hiroshi Itoh
Journal:  Rev Diabet Stud       Date:  2010-11-10

5.  In vivo consequence of vitamin C insufficiency in liver injury: vitamin C ameliorates T-cell-mediated acute liver injury in gulo(-/-) mice.

Authors:  Seyeon Bae; Chung-Hyun Cho; Hyemin Kim; Yejin Kim; Hang-Rae Kim; Young-Il Hwang; Jung Hwan Yoon; Jae Seung Kang; Wang Jae Lee
Journal:  Antioxid Redox Signal       Date:  2013-04-18       Impact factor: 8.401

6.  Blockade of IL-33 ameliorates Con A-induced hepatic injury by reducing NKT cell activation and IFN-γ production in mice.

Authors:  Jie Chen; Lihua Duan; Ali Xiong; Hongwei Zhang; Fang Zheng; Zheng Tan; Feili Gong; Min Fang
Journal:  J Mol Med (Berl)       Date:  2012-09-16       Impact factor: 4.599

7.  Sodium tanshinone IIA sulfonate protects mice from ConA-induced hepatitis via inhibiting NF-kappaB and IFN-gamma/STAT1 pathways.

Authors:  Yan Xu; Dechun Feng; Ying Wang; Shuting Lin; Lingyun Xu
Journal:  J Clin Immunol       Date:  2008-05-24       Impact factor: 8.317

8.  Pivotal role of dendritic cell-derived CXCL10 in the retention of T helper cell 1 lymphocytes in secondary lymph nodes.

Authors:  Hiroyuki Yoneyama; Shosaku Narumi; Yanyun Zhang; Masako Murai; Marco Baggiolini; Antonio Lanzavecchia; Takafumi Ichida; Hitoshi Asakura; Kouji Matsushima
Journal:  J Exp Med       Date:  2002-05-20       Impact factor: 14.307

9.  Protective effect of galangin in Concanavalin A-induced hepatitis in mice.

Authors:  Qingqiong Luo; Liping Zhu; Jieying Ding; Xing Zhuang; Lili Xu; Fuxiang Chen
Journal:  Drug Des Devel Ther       Date:  2015-06-10       Impact factor: 4.162

10.  Sophocarpine Protects Mice from ConA-Induced Hepatitis via Inhibition of the IFN-Gamma/STAT1 Pathway.

Authors:  Xiu-Xiu Sang; Rui-Lin Wang; Cong-En Zhang; Shi-Jing Liu; Hong-Hui Shen; Yu-Ming Guo; Ya-Ming Zhang; Ming Niu; Jia-Bo Wang; Zhao-Fang Bai; Xiao-He Xiao
Journal:  Front Pharmacol       Date:  2017-03-21       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.